Dino Mehic: Can Global Coagulation Testing Detect Abnormalities in BDUC?
Dino Mehic, Physician Scientist at the Medical University of Vienna, shared a post on LinkedIn about a recent article he and his colleagues co-authored, adding:
“Can global coagulation testing detect abnormalities in BDUC?
Bleeding disorder of unknown cause (BDUC) remains one of the most common diagnoses in patients with a lifelong bleeding tendency, yet routine laboratory testing is normal and objective biomarkers are lacking.
In our study of 464 BDUC patients from the Vienna Bleeding Biobank and 100 healthy controls, we evaluated non-activated whole-blood viscoelastic testing (ROTEM) to determine whether global assays capture hemostatic alterations.
Key findings:
- BDUC patients showed delayed clot formation and reduced maximum lysis resulting in an impaired overall clot formation profile.
- ROTEM parameters discriminated BDUC patients from healthy controls with good performance (ROC-AUC up to 0.81 using machine-learning models).
- Hemoglobin was the strongest determinant of ROTEM variability among clinical and laboratory parameters.
- However, ROTEM parameters did not correlate with bleeding severity, highlighting the complexity of bleeding phenotypes in BDUC.
Take-home: Global viscoelastic testing reveals detectable but modest alterations in clot formation in BDUC, yet these changes do not explain bleeding severity.
The search for robust biomarkers and underlying mechanism in BDUC therefore continues.
Grateful to all collaborators and the Vienna Bleeding Biobank team: Johanna Gebhart, Cihan Ay, Alice Assinger, Bernd Jilma, Maximilian Koeller.”
Title: Abnormal whole-blood viscoelastic testing in patients with bleeding disorder of unknown cause
Authors: Dino Mehic, Tim Dreier, Maximilian C. Koeller, Justin Oosterlee, Christa Drucker, Alice Assinger, Bernd Jilma, Cihan Ay, Ingrid Pabinger, Johanna Gebhart
Read the Full Article on Blood Vessels, Thrombosis and Hemostasis.
Other articles featuring Dino Mehic on Hemostasis Today.
-
Apr 22, 2026, 07:56Shruti Kharat: Closing the Gap in Early Detection of Factor VIII Inhibitors
-
Apr 22, 2026, 07:46Gregory Piazza: Ushering in a New Era in PE Therapy and Improved Clinical Outcomes for Our Patients
-
Apr 22, 2026, 07:40Akshat Jain: WIL33 Study Advances Factor Prophylaxis in Children with von Willebrand Disease
-
Apr 22, 2026, 07:36Selma Turkovic: Blood Transfusion Education and Discussion Group Webinar 61
-
Apr 22, 2026, 07:34Aikati Anastasiou: Advancing Stroke Imaging Insights from the DISTAL Trial
-
Apr 22, 2026, 07:26Maxime Dely: How Do We Balance Benefit and Risk in Chronic Hematologic Diseases?
-
Apr 22, 2026, 07:19Sarah Richardson: Bringing Insights from HFA Symposium Back to Real Life
-
Apr 22, 2026, 07:17Karuna Kumar: Interesting Trial from Gambia on Treating Iron Deficiency in Children
-
Apr 22, 2026, 07:12Mary Catherine Moffett: Celebrating 32 Years of Patient-Centered Advocacy with the Hemophilia Federation of America